Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Long-Term Investments (2020 - 2024)

Alvotech's (ALVO) quarterly Long-Term Investments came in at $18.5 million in Q1 2024, little changed quarter-over-quarter from $18.5 million in Q4 2023.

Analysis

Alvotech (ALVO) Long-Term Investments (2020 - 2024) Analysis & Trends

Alvotech (ALVO) has reported Long-Term Investments for 5 consecutive years, with $18.5 million the latest figure, recorded in Q1 2024.

  • For the quarter ending Q1 2024, Long-Term Investments changed N/A year-over-year to $18.5 million; the trailing twelve-month figure through Mar 2024 stood at $18.5 million (changed N/A YoY), and the FY2023 full-year result was $18.5 million, down 61.92% from the prior year.
  • Long-Term Investments held at $18.5 million in Q1 2024 per ALVO's latest filing, from $18.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $56.7 million in Q4 2020 and bottomed at $18.5 million in Q4 2023.
  • Historically, Long-Term Investments has averaged $41.8 million across 5 years, with a median of $48.6 million in 2022.
  • The sharpest annual moves came in 2021 and 2023: Long-Term Investments retreated 2.42% in 2021, then plunged 61.92% in 2023.
  • Over 5 years, Long-Term Investments stood at $56.7 million in 2020, then fell by 2.42% to $55.3 million in 2021, then retreated by 12.18% to $48.6 million in 2022, then sank by 61.92% to $18.5 million in 2023, then changed by 0.0% to $18.5 million in 2024.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $18.5 million, $18.5 million, and $43.6 million for Q1 2024, Q4 2023, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 848.23 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 16.30 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 12.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 18.49 Mn
Dec 31, 2023 18.49 Mn
Jun 30, 2023 43.61 Mn
Dec 31, 2022 48.57 Mn
Jun 30, 2022 51.33 Mn
Dec 31, 2021 55.31 Mn
Dec 31, 2020 56.68 Mn